Antares Faces Records Suit Over Testosterone Drug Troubles
A regulatory smackdown dealt to Antares Pharma Inc. over a new injectable testosterone treatment led a shareholder to file a books and records suit in Delaware Chancery Court on Wednesday with...To view the full article, register now.
Already a subscriber? Click here to view full article